# psoriasis - claude-opus-4-8

- Benchmark system: E2seq + Agent RAG
- Repeat: 2
- Task type: DISEASE-STATE
- Tissue / sample source: lesional skin
- Comparison or endpoint: psoriatic lesional skin versus normal control skin
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: Anthropic / claude-opus-4-8
- Message SHA-256: d1a33d3f606c81814c4fb94a6c63c8f1abebd3bde37d769e82eae4772d8ff873
- Response HTTP status: 200
- Prompt tokens: 43894
- Completion tokens: 16775
- Reasoning tokens: 0
- Total tokens: 60669
- API requests reported: 5
- Elapsed seconds: 304.139
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1150.303
- Question handoff seconds: 1163.566
- Final benchmark system: E2seq; file rank 2/5; original repeat 2; model vendor: Anthropic

---
# Multidimensional Interpretation of Psoriatic Lesional Skin Transcriptomics

## 1. Overall Biological Interpretation

The transcriptomic signature of psoriatic lesional skin reflects a state of sustained immune activation coupled with profound epithelial remodeling. The dataset is dominated by upregulated genes (90/100), consistent with the hyperproliferative and inflammatory nature of psoriatic plaques. The molecular profile reveals three interconnected biological themes:

First, **IL-17/IL-36 axis hyperactivation** drives the inflammatory cascade. Multiple IL-17-responsive antimicrobial peptides (DEFB4A/4B, DEFB103A/B, S100A12, PI3) and IL-36 family cytokines (IL36A, IL36G) are among the most significantly upregulated genes (log2FC 5.7-11.4, FDR < 1e-90), indicating a self-amplifying inflammatory loop characteristic of psoriasis pathogenesis.

Second, **aberrant keratinocyte differentiation and cornification** is evident through massive upregulation of late cornified envelope proteins (SPRR family members with log2FC 4.0-7.3) and altered keratins (KRT6A). The coordinated expression of these structural proteins reflects the hyperproliferative, parakeratotic epidermis typical of psoriatic lesions.

Third, **metabolic and lipid processing reprogramming** emerges through upregulation of aldo-keto reductases (AKR1B10, AKR1B15, log2FC 5.2-6.3) and fatty acid binding proteins (FABP5), while select genes involved in lipid homeostasis show downregulation (BTC, CYP2W1), suggesting disrupted epidermal barrier lipid metabolism.

The limited downregulated genes (10/100) include BTC (betacellulin, log2FC -4.3), potentially reflecting impaired EGFR-mediated homeostatic signaling that normally restrains keratinocyte proliferation.

## 2. Core Biological Programs

### Program 1: IL-17/IL-36-Driven Antimicrobial Response

**Direction:** Strongly upregulated  
**Major supporting genes:** IL36A (log2FC 11.37), IL36G (5.68), IL19 (7.58), IL20 (5.67), DEFB4A (11.18), DEFB4B (11.03), DEFB103A (5.76), DEFB103B (5.75), S100A12 (8.33), PI3 (9.24)  
**Pathway mapping:** KEGG IL-17 signaling pathway, GO Antimicrobial Humoral Response (GO:0019730)

**Biological rationale:**  
This program represents the core pathogenic immune signature of psoriasis. The IL-36 cytokines (IL-36α and IL-36γ) are master amplifiers of skin inflammation, produced by activated keratinocytes and driving recruitment and activation of neutrophils and Th17 cells. Their extreme upregulation (among the top differentially expressed genes) indicates active inflammatory signaling. 

The coordinated induction of β-defensins (DEFB4A/4B showing the highest fold-changes in the dataset at ~11 log2FC) and S100 alarmins reflects downstream IL-17/IL-36 effects. These antimicrobial peptides are directly induced by IL-17A/F and serve dual roles: killing microorganisms and acting as damage-associated molecular patterns (DAMPs) that perpetuate inflammation. The IL-19 and IL-20 cytokines, also IL-10 family members linked to keratinocyte hyperproliferation, further support this Th17/IL-23 axis activation.

Network evidence shows CCR6 (chemokine receptor critical for Th17 cell recruitment) connects to multiple defensins, providing mechanistic support for the immune-epithelial crosstalk.

**Evidence strength and limitations:**  
Strong evidence based on: (1) multiple independent genes within the same pathway showing extreme effect sizes and statistical significance (FDR < 1e-90), (2) established IL-17/IL-36 axis in psoriasis pathogenesis supported by successful therapeutic targeting (anti-IL-17 biologics), (3) pathway enrichment and network connectivity.

Limitations: The cross-sectional design cannot distinguish drivers from consequences. While IL-36 cytokines are elevated, the cellular source (keratinocytes vs infiltrating immune cells) cannot be determined from bulk tissue data. No independent cohort validation is available in the current dataset.

---

### Program 2: Hyperproliferative Epithelial Differentiation and Cornification

**Direction:** Strongly upregulated  
**Major supporting genes:** SPRR2A (7.31), SPRR2B (6.38), SPRR2D (5.92), SPRR2E (3.99), SPRR3 (7.18), LCE3A, LCE3D, KRT6A (4.30), PI3 (9.24), SERPINB3 (6.74), SERPINB4, SERPINB13  
**Pathway mapping:** Reactome "Formation of the cornified envelope" (R-HSA-6809371), GO Epidermis Development (GO:0008544)

**Biological rationale:**  
The small proline-rich repeat (SPRR) proteins and late cornified envelope (LCE) proteins are structural components of the cornified envelope that forms the outermost barrier of the epidermis. Their massive coordinated upregulation reflects the accelerated and aberrant keratinocyte differentiation program in psoriatic plaques.

In normal skin, these proteins are expressed late in terminal differentiation. In psoriasis, their premature and excessive expression (log2FC 4-7) indicates loss of normal differentiation control, resulting in the characteristic parakeratotic scaling. KRT6A, typically expressed only in wound healing or disease states, replaces normal differentiation-specific keratins, marking the "activated" keratinocyte phenotype.

STRING network analysis reveals SPRR1B as a hub connecting 8 selected genes (KRT6A, multiple SPRR family members), demonstrating the coordinated regulation of this cornification module. SPRR2B connects to LCE proteins, further supporting the programmatic nature of this response.

The elafin-related serine protease inhibitors (SERPINB3/4/13) regulate desquamation and barrier formation, with their upregulation potentially representing a compensatory response to inflammatory proteases.

**Evidence strength and limitations:**  
Strong evidence: (1) 12 genes mapping to Reactome cornified envelope pathway, (2) consistent high fold-changes across functionally related genes, (3) network connectivity demonstrating coordinated regulation, (4) alignment with known psoriatic histopathology (parakeratosis, hyperkeratosis).

Limitations: The functional consequence of SPRR overexpression—whether protective barrier compensation or pathologic parakeratosis—cannot be distinguished from expression data alone. The temporal sequence (whether differentiation defects precede or follow inflammation) remains unclear. Protein-level validation and functional studies would be needed to confirm barrier function impact.

---

### Program 3: Lipid Metabolism and Barrier Function Dysregulation

**Direction:** Mixed (predominantly upregulated lipid processing enzymes, selective downregulation of homeostatic regulators)  
**Major supporting genes:** AKR1B10 (6.27), AKR1B15 (5.23), FABP5 (3.65), PLA2G4D (4.62), PLBD1 (2.08), ABCG4 (4.75) [upregulated]; BTC (-4.30), CYP2W1 (-4.70) [downregulated]  
**Pathway mapping:** GO lipid metabolic process, KEGG metabolic pathways

**Biological rationale:**  
Epidermal barrier function critically depends on precisely regulated lipid synthesis and processing. This program reflects profound metabolic reprogramming affecting barrier lipid homeostasis.

The aldo-keto reductases (AKR1B10, AKR1B15) are among the top upregulated genes (log2FC 5-6). These enzymes reduce aldehydes and ketones and influence prostaglandin and retinoid metabolism. AKR1B10 specifically regulates fatty acid and lipid synthesis; its overexpression in psoriasis may redirect lipid metabolism toward inflammatory mediators rather than structural barrier lipids.

FABP5 (fatty acid binding protein 5) transports fatty acids and regulates keratinocyte differentiation through PPAR signaling. Its upregulation (3.65 log2FC) may reflect increased fatty acid flux but could impair normal differentiation signaling.

Phospholipase A2 enzymes (PLA2G4D/E) release arachidonic acid for eicosanoid synthesis, directly linking lipid metabolism to inflammation. Their upregulation provides substrate for prostaglandin and leukotriene production.

Conversely, betacellulin (BTC, log2FC -4.30), an EGFR ligand that promotes normal keratinocyte homeostasis and lipid synthesis, is downregulated, potentially impairing homeostatic lipid production. CYP2W1 downregulation may reflect altered retinoid and lipid-soluble vitamin metabolism.

**Evidence strength and limitations:**  
Moderate evidence: (1) multiple genes in lipid metabolic pathways, (2) biologically coherent pattern linking altered lipid processing to barrier dysfunction, (3) supported by known barrier defects in psoriasis.

Limitations: This program is more heterogeneous than Programs 1-2, with genes spanning different lipid metabolic sub-pathways. The functional integration—whether these changes collectively impair barrier lipids or represent compensatory responses—requires lipidomic validation. Only 25/100 genes had metabolite database records, limiting metabolic network interpretation. The causal relationship to barrier dysfunction versus secondary inflammatory effects is unclear.

---

### Program 4: Chemokine-Mediated Immune Cell Recruitment

**Direction:** Upregulated  
**Major supporting genes:** CXCL13 (5.89), WNT5A (2.53), TNIP3 (7.28), ZC3H12A (3.85), HRH2 (3.27)  
**Pathway mapping:** KEGG Cytokine-cytokine receptor interaction, GO Response to Lipopolysaccharide (GO:0032496)

**Biological rationale:**  
Beyond the IL-17/IL-36 cytokine axis, this program reflects the broader chemokine and immune trafficking network that maintains psoriatic inflammation.

CXCL13, a B-cell and follicular helper T-cell chemoattractant, is strongly upregulated (5.89 log2FC). While psoriasis is traditionally viewed as T-cell-mediated, CXCL13 elevation suggests B-cell and tertiary lymphoid structure formation in chronic lesions, consistent with recent single-cell data showing B-cell populations in psoriatic skin.

WNT5A, a non-canonical WNT ligand, regulates both keratinocyte proliferation and inflammatory cell migration. Its upregulation connects tissue remodeling to immune cell positioning.

TNIP3 and ZC3H12A are negative regulators of NF-κB signaling. Their upregulation likely represents compensatory anti-inflammatory feedback attempting to dampen the inflammatory cascade—a common pattern in chronic inflammation where negative regulators are induced but insufficient to resolve disease.

Histamine receptor 2 (HRH2) upregulation may reflect mast cell involvement and histamine-mediated vascular changes contributing to erythema.

**Evidence strength and limitations:**  
Moderate evidence: (1) genes span immune recruitment and regulation, (2) consistent with known psoriatic infiltrate composition, (3) supported by pathway enrichment (cytokine-cytokine receptor interaction).

Limitations: This program is less integrated than Programs 1-2, representing diverse aspects of immune regulation rather than a single coherent module. CXCL13's role in psoriasis is less established than in other immune disorders. The cellular sources and targets of these chemokines cannot be resolved from bulk data. The functional significance of negative regulator upregulation (compensatory vs. insufficient) requires functional validation.

---

### Program 5: Keratinocyte Stress Response and Intercellular Communication

**Direction:** Upregulated  
**Major supporting genes:** GJB2 (4.42), GJB6 (3.02), KYNU (4.42), HPSE (2.92), RHCG (5.29), SLC6A14 (4.47)  
**Pathway mapping:** GO epidermis development, cellular response to stress

**Biological rationale:**  
This program captures keratinocyte adaptation to the inflammatory microenvironment through altered gap junction communication and metabolic stress responses.

Gap junction proteins connexin 26 and 30 (GJB2, GJB6) mediate direct intercellular communication and coordinate keratinocyte differentiation. Their upregulation may reflect attempts to coordinate the hyperproliferative response or may represent maladaptive signaling that propagates aberrant differentiation signals across the epidermis. GJB2 mutations cause skin disorders, highlighting its importance in epidermal homeostasis.

Kynureninase (KYNU, 4.42 log2FC) metabolizes kynurenine, a tryptophan metabolite with immunomodulatory properties. Elevated KYNU may alter local tryptophan-kynurenine balance, affecting T-cell function and inflammation. This connects amino acid metabolism to immune regulation.

Heparanase (HPSE) degrades heparan sulfate, remodeling the extracellular matrix and releasing sequestered growth factors and cytokines. Its upregulation facilitates inflammatory cell infiltration and sustained growth factor signaling.

Transporters (RHCG - ammonia transporter, SLC6A14 - amino acid transporter) indicate altered keratinocyte metabolic demands in the hyperproliferative, inflamed state.

**Evidence strength and limitations:**  
Moderate-to-weak evidence: (1) genes are functionally diverse, unified by keratinocyte stress/adaptation theme, (2) individual genes have plausible mechanistic links to psoriasis biology, (3) less pathway/network integration than Programs 1-3.

Limitations: This is the most heterogeneous program, representing stress responses across multiple systems rather than a single coherent pathway. The functional consequences of gap junction and transporter changes require electrophysiological and metabolic studies. Limited network connectivity among these genes suggests they may represent parallel stress responses rather than an integrated program. This program has the weakest evidence for being a unified biological module and borders on an "other stress-related genes" category.

---

## Summary

The psoriatic transcriptome is dominated by two tightly integrated and well-supported programs: **(1) IL-17/IL-36-driven antimicrobial inflammation** and **(2) hyperproliferative epithelial differentiation/cornification**, which represent the pathogenic core of psoriasis—the immune-epithelial crosstalk that self-amplifies to create persistent plaques. **(3) Lipid metabolism dysregulation** provides a mechanistic link to barrier dysfunction and potentially to disease initiation. **(4) Chemokine-mediated immune recruitment** and **(5) keratinocyte stress responses** represent important but more heterogeneous supporting processes.

The predominantly upregulated profile (90% of genes) and the extreme effect sizes (many genes >5 log2FC, FDR < 1e-80) reflect the severe, sustained activation state of psoriatic lesions. The absence of independent cohort validation and the cross-sectional design limit causal inference, but the concordance with established psoriasis biology and therapeutic targets (IL-17, IL-23 pathway blockade) provides external validation of the core inflammatory program.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=6, external claims checked=0, external mismatches=0, status=needs review.

Answer model API: Anthropic / claude-opus-4-8

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 91/100 selected items (records returned); cbioportal 91/100 selected items (records returned); chembl 11/100 selected items (partially returned; some queries failed); civic 4/100 selected items (records returned); clinicaltrials 40/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 44/100 selected items (partially returned; some queries failed); europepmc 848 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 83/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 76/100 selected items (records returned); humanbase 100/100 selected items (records returned); intact 79/100 selected items (records returned); mygene 100/100 selected items (records returned); omnipath 36/100 selected items (records returned); opentargets 90/100 selected items (records returned); pubmed 669 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 80/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 80/100 selected items (records returned)
Local databases: gutmgene 2/100 selected items (records returned); hmdb 25/100 selected items (records returned); string 78/100 selected items (records returned); trrust 17/100 selected items (records returned)
